title: Allogeneic dendritic cell induction of HIV-specific cytotoxic T lymphocyte responses from T cells of HIV type 1-infected and uninfected individuals.
abstract: The potential benefit of T cell-based vaccination for HIV-1 infection remains to be determined. Cytotoxic T lymphocytes (CTLs) appear to clear substantial populations of HIV-1 virus in vivo, although CTL activity may contribute to the decline in CD4+ T cell count observed in the course of the disease. To investigate further the role of specific CTL responses in the control of HIV-1 replication, we raised primary CTL lines against a panel of conserved HIV-1 epitopes using blood-derived dendritic cells as antigen-presenting cells (APCs). Specific primary human CTL responses were induced against HLA-A*0201-restricted peptides with dendritic cells from HIV-1-seronegative donors. This method of immunization elicited cytotoxic activities capable of recognizing endogenously processed antigen. The CTL induction protocol was extended in order to explore the capacity of HLA-matched allogeneic dendritic cells to evoke novel CTL responses in T cells from an HIV-seropositive asymptomatic individual. Allogeneic peptide-pulsed dendritic cells from a healthy sibling were capable of eliciting a CTL response directed against an HIV epitope (env814: SLLNATDIAV) that was initially not detected in the CTL effector population of the HIV-1-infected patient. The possibility of manipulating CTL specificity directed against multiple conserved HIV-1 epitopes represents a significant step in the evaluation of T cell-based vaccination for treatment of disease.
authors.affiliation: Center for AIDS Research, Stanford University Medical Center, California 94305, USA.
authors.forename: M
authors.initials: M
authors.lastname: Dupuis
authors.forename: M V
authors.initials: MV
authors.lastname: Peshwa
authors.forename: C
authors.initials: C
authors.lastname: Benike
authors.forename: S K
authors.initials: SK
authors.lastname: Kundu
authors.forename: E G
authors.initials: EG
authors.lastname: Engleman
authors.forename: W C
authors.initials: WC
authors.lastname: Van Schooten
authors.forename: T C
authors.initials: TC
authors.lastname: Merigan
mesh_terms: D000956:Antigens, Viral / Q000276:immunology; D002460:Cell Line; D003713:Dendritic Cells / Q000276:immunology*; D006679:HIV Seropositivity / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D015234:HLA-A Antigens / Q000276:immunology; D006801:Humans; D009679:Nuclear Family; D009842:Oligopeptides / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D000956:Antigens, Viral; D015234:HLA-A Antigens; D009842:Oligopeptides